Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA-511-3p regulates Aβ1–40 induced decreased cell viability and serves as a candidate biomarker in Alzheimer's disease

25 May 2023

Abstract excerpt

BACKGROUND: Alzheimer's disease (AD) is a progressive neurodegenerative disease with high incidence in the elderly population. MicroRNAs have been reported to abnormally expressed in patients with AD. In this study, we investigated the role of inflammation-related miR-511-3p in AD patients and AD cell models. METHOD: The level of miR-511-3p was quantified by Real-Time PCR. The diagnostic value was evaluated by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to MicroRNA in disease regulation
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37121335
DOI: 10.1016/j.exger.2023.112195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA-511-3p regulates Aβ1–40 induced decreased cell viability and serves as a candidate biomarker in Alzheimer's diseasePMID 37121335Read ↗

The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's DiseaseSemantic proximity Read ↗

MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapySemantic proximity Read ↗

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic BiomarkersSemantic proximity Read ↗

Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease ProgressionSemantic proximity Read ↗

MiRNA‐501‐3p and MiRNA‐502‐3p: A promising biomarker panel for Alzheimer's diseaseSemantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNA Dysregulation in Alzheimer's DiseaseSemantic proximity Read ↗

Serum Aberrant Expression of miR-24-3P and Its Diagnostic Value in Alzheimer’s DiseaseSemantic proximity Read ↗

miR-519a-3p, found to regulate cellular prion protein during Alzheimer’s disease pathogenesis, as a biomarker of asymptomatic stagesSemantic proximity Read ↗

MicroRNAs in Alzheimer’s DiseaseSemantic proximity Read ↗

miRNAs as Therapeutic Tools in Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNA‑4722‑5p and microRNA‑615‑3p serve as potential biomarkers for Alzheimer's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.